Last $19.17 USD
Change Today -0.02 / -0.10%
Volume 73.8K
ANGO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

angiodynamics inc (ANGO) Snapshot

Open
$19.18
Previous Close
$19.19
Day High
$19.30
Day Low
$19.09
52 Week High
12/18/14 - $19.30
52 Week Low
04/15/14 - $13.06
Market Cap
683.5M
Average Volume 10 Days
178.5K
EPS TTM
$0.29
Shares Outstanding
35.7M
EX-Date
--
P/E TM
66.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for ANGIODYNAMICS INC (ANGO)

angiodynamics inc (ANGO) Related Businessweek News

No Related Businessweek News Found

angiodynamics inc (ANGO) Details

AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly and through distributors in the United States and internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

1,300 Employees
Last Reported Date: 08/14/14
Founded in 1988

angiodynamics inc (ANGO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $873.6K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $367.1K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $308.3K
Senior Vice President of Global Franchise, On...
Total Annual Compensation: $276.8K
Senior Vice President of Administration
Total Annual Compensation: $291.6K
Compensation as of Fiscal Year 2014.

angiodynamics inc (ANGO) Key Developments

AngioDynamics Inc. Wins Contract to Provide PICC Products to HealthTrust

AngioDynamics announced that it signed an agreement with HealthTrust covering peripherally inserted central catheter or PICC products. Effective January 1, 2015, ANGO's entire PICC portfolio, including its thromboresistant BioFlo PICC product line and Celerity tip location system, will be available to HealthTrust members. The company reported that this is its seventh contract with HealthTrust, with its others covering fluid management, dialysis and core peripheral vascular products.

AngioDynamics Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM

AngioDynamics Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Joseph M. Devivo, Chief Executive Officer, President and Director.

AngioDynamics Inc. Reaffirms Earnings Guidance for the Second Quarter and Full Year Ending May 2015

AngioDynamics Inc. reaffirmed earnings guidance for the second quarter and fiscal 2015. For the quarter, the company expects earnings per share of $0.14-$0.17, excluding non-recurring items, and revenues of $89 million-$92 million, in-line with the consensus of $0.15 per share on revenues of $90.9 million. For the year ending May 2015, the company expects earnings per share of $0.65-$0.71, excluding non-recurring items, and revenues of $362 million-$368 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANGO:US $19.17 USD -0.02

ANGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aerovironment Inc $27.82 USD +0.43
CTS Corp $18.28 USD -0.06
Micrel Inc $14.30 USD +0.13
Raven Industries Inc $25.46 USD -0.06
Sparton Corp $28.25 USD +0.05
View Industry Companies
 

Industry Analysis

ANGO

Industry Average

Valuation ANGO Industry Range
Price/Earnings 100.0x
Price/Sales 1.9x
Price/Book 1.3x
Price/Cash Flow 33.1x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANGIODYNAMICS INC, please visit www.angiodynamics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.